About Index Trending news
Analyze
Pricing
PolyPid

PolyPid

Work at PolyPid? Add yourself to this profile

PolyPid

PolyPid is a clinical stage emerging specialty pharmaceutical company, engaged in research and development of products based on PLEX (PolymerLipid Encapsulation MatriX), a proprietary drug delivery technology.

Elsewhere

Alexa global traffic share

10 Nov 2016
$5,300,000
Venture capital (Series UNDISCLOSED)
24 Feb 2016
$22,000,000
Venture capital (Series D)
Aurum Ventures, Shavit Capital, Chaim Hurvitz

PolyPid Closes $22M Equity Financing

FinSMEs
+1
18 Feb 2016
$8,140,000
Venture capital (Series C)